Arena Pharmaceuticals has paid $60 million for an option to acquire Aristea Therapeutics, a private biotech founded in 2018 to develop an experimental inflammatory drug discovered by AstraZeneca. Arena’s option deal was accompanied by a $63 million Series B fundraising round for Aristea that included contributions from Fidelity Managment & Research, Aristea’s original lead investor Novo Holdings […]

Flexion Therapeutics is committed to helping the more than 15 million Americans with osteoarthritis, despite treatment of the degenerative musculoskeletal disorder at a relative standstill, with short-term pain management with steroid injections considered standard care. The company developed triamcinolone acetonide extended-release injectable suspension (Zilretta), which was approved by the FDA in 2017, that resulted in […]

Aduhelm demonstrated a consistent treatment effect for slowing decline in cognitive, functional and behavioral domains among patients with early Alzheimer’s disease in item-level analysis of the phase 3 EMERGE study. Results from this analysis demonstrated consistency with results from the primary analysis of clinical endpoints for Aduhelm (aducanumab, Biogen/Eisai), according to the study results. Researchers […]